- Home
- IMMP vs RFMZ Comparison
IMMP vs RFMZ Comparison
Compare IMMP & RFMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMMP
- RFMZ
- Stock Information
- Founded
- IMMP 1987
- RFMZ 2021
- Country
- IMMP Australia
- RFMZ United States
- Employees
- IMMP N/A
- RFMZ N/A
- Industry
- IMMP Biotechnology: Pharmaceutical Preparations
- RFMZ Trusts Except Educational Religious and Charitable
- Sector
- IMMP Health Care
- RFMZ Finance
- Exchange
- IMMP Nasdaq
- RFMZ Nasdaq
- Market Cap
- IMMP 304.0M
- RFMZ 339.0M
- IPO Year
- IMMP N/A
- RFMZ N/A
- Fundamental
- Price
- IMMP $2.17
- RFMZ $13.65
- Analyst Decision
- IMMP Buy
- RFMZ
- Analyst Count
- IMMP 2
- RFMZ 0
- Target Price
- IMMP $8.50
- RFMZ N/A
- AVG Volume (30 Days)
- IMMP 147.6K
- RFMZ 76.6K
- Earning Date
- IMMP 12-27-2024
- RFMZ 01-01-0001
- Dividend Yield
- IMMP N/A
- RFMZ 7.43%
- EPS Growth
- IMMP N/A
- RFMZ N/A
- EPS
- IMMP N/A
- RFMZ 0.65
- Revenue
- IMMP $2,563,302.00
- RFMZ N/A
- Revenue This Year
- IMMP N/A
- RFMZ N/A
- Revenue Next Year
- IMMP $10.84
- RFMZ N/A
- P/E Ratio
- IMMP N/A
- RFMZ $21.49
- Revenue Growth
- IMMP 9.59
- RFMZ N/A
- 52 Week Low
- IMMP $1.66
- RFMZ $11.28
- 52 Week High
- IMMP $3.34
- RFMZ $14.57
- Technical
- Relative Strength Index (RSI)
- IMMP 55.07
- RFMZ 32.12
- Support Level
- IMMP $2.00
- RFMZ $14.10
- Resistance Level
- IMMP $2.39
- RFMZ $14.31
- Average True Range (ATR)
- IMMP 0.13
- RFMZ 0.13
- MACD
- IMMP 0.01
- RFMZ -0.05
- Stochastic Oscillator
- IMMP 54.17
- RFMZ 0.92
About IMMP Immutep Limited
Immutep Ltd is a globally active biotechnology company developing immunotherapy products for cancer and autoimmune diseases. Its main product is IMP321, which involves clinical development for the treatment of cancer indications. The company is also focused on the development of other products, which include IMP701, which is a blocking anti-LAG-3 antibody for cancer and is in Phase I of its clinical trials, and CVac, which is a personalized immunocellular therapeutic investigated for the treatment of epithelial cancer. Geographically all the business activity of the firm is functioned through the region of Australia.
About RFMZ RiverNorth Flexible Municipal Income Fund II Inc.
RiverNorth Flex Muni Income Fund II Inc is a diversified, closed-end management investment company. Its primary investment objective is to seek current income exempt from regular U.S. federal income taxes. The fund's secondary investment objective is total return.